IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 50 filers reported holding IKENA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,045 | -30.8% | 15,715 | +4.9% | 0.00% | – |
| Q2 2023 | $98,315 | +111.3% | 14,987 | +11.1% | 0.00% | – |
| Q1 2023 | $46,532 | +376.8% | 13,488 | +267.6% | 0.00% | – |
| Q4 2022 | $9,760 | -94.7% | 3,669 | -92.9% | 0.00% | – |
| Q3 2022 | $183,000 | -44.9% | 51,515 | -31.4% | 0.00% | – |
| Q2 2022 | $332,000 | +325.6% | 75,107 | +481.7% | 0.00% | – |
| Q1 2022 | $78,000 | -49.0% | 12,911 | +6.4% | 0.00% | – |
| Q4 2021 | $153,000 | +273.2% | 12,140 | +275.7% | 0.00% | – |
| Q3 2021 | $41,000 | +720.0% | 3,231 | +787.6% | 0.00% | – |
| Q2 2021 | $5,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |